A carregar...

Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations

Utilizing the concept of synthetic lethality has provided new opportunities for the development of targeted therapies, by allowing the targeting of loss of function genetic aberrations. In cancer cells with BRCA1 or BRCA2 loss of function, which harbor deficiency of DNA repair by homologous recombin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dedes, Konstantin J, Wilkerson, Paul M, Wetterskog, Daniel, Weigelt, Britta, Ashworth, Alan, Reis-Filho, Jorge S
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117132/
https://ncbi.nlm.nih.gov/pubmed/21487248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cc.10.8.15273
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!